Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Journal of Functional Biomaterials|June 25, 2025
Potential Applications of PRP-Enhanced Polybutylene Succinate Graft as Vascular Access for Chemotherapy in Oncological Patients: A Systematic ReviewAndrea Gottardo, Giulia Bonventre, Tancredi Didier Bazan Russo, et al.
Therapeutic Advances in Medical Oncology|October 14, 2021
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analysesValerio Gristina, Antonio Galvano, Luisa Castellana, et al.
International Journal of Molecular Sciences|October 16, 2024
Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of LiteratureAndrea Gottardo, Gabriele Tulone, Nicola Pavan, et al.
Advances in Therapy|August 22, 2019
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, et al.
Expert Review of Molecular Diagnostics|September 13, 2024
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancerValerio Gristina, Francesco Pepe, Carlo Genova, et al.
Frontiers in Endocrinology|December 11, 2023
The role of bone modifying agents for secondary osteoporosis prevention and pain control in post-menopausal osteopenic breast cancer patients undergoing adjuvant aromatase inhibitorsAntonio Galvano, Valerio Gristina, Dalila Scaturro, et al.
Critical Reviews in Oncology/Hematology|June 7, 2026
Advances in early-stage lung cancer patients: from preanalytics to molecular analysisFrancesco Pepe, Valerio Gristina, Tancredi Didier Bazan Russo, et al.
Journal of Thoracic Disease|August 18, 2020
KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal settingMariantonia Nacchio, Roberta Sgariglia, Valerio Gristina, et al.
Expert Review of Molecular Diagnostics|August 8, 2023
The significance of tissue-agnostic biomarkers in solid tumors: the more the merrier?Valerio Gristina, Pasquale Pisapia, Nadia Barraco, et al.
Cancers|March 1, 2020
Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-AnalysisAntonio Galvano, Marta Castiglia, Sergio Rizzo, et al.
Pageof 6